Baxter recalls large number of units of sodium chloride and dextrose due to sterility concerns

The voluntary recall was posted in three separate notifications on the FDA’s website last week.

Baxter Pharmaceutical has issued a voluntary recall for more than 427,000 bags of 0.9% sodium chloride injection and 54,528 containers of 5% dextrose injection due to a lack of assurance of sterility and the possibility of leakage.

The voluntary recall was posted in three separate notifications on the FDA’s website last week.

The dextrose recall is for 100-ml Viaflex plastic containers distributed across the U.S., Puerto Rico and the United Arab Emirates.

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

The recall for 427,104 bags of sodium chloride is for both 100 ml and 250 ml Viaflex container bags distributed mostly in the U.S. with some 100-ml bags in Puerto Rico and the UAE.

The recall initiation date for all three notices was July 6.

Read more on

Suggested Articles

With momentum building in Pfizer’s gene therapy programs, it has bought a building in North Carolina where it will consolidate clinical manufacturing.

Novartis has gotten out in front of an FDA, and its competitors, by halting worldwide distribution of its generic Zantac.

Roche has spent years reprioritizing its manufacturing spending, and as part of that process, it's exiting a small molecule site in Ireland.